ID   GAMT_RAT                Reviewed;         236 AA.
AC   P10868;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   24-JUL-2024, entry version 155.
DE   RecName: Full=Guanidinoacetate N-methyltransferase;
DE            EC=2.1.1.2;
GN   Name=Gamt;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=3277179; DOI=10.1073/pnas.85.3.694;
RA   Ogawa H., Date T., Gomi T., Konishi K., Pitot H.C., Cantoni G.L.,
RA   Fujioka M.;
RT   "Molecular cloning, sequence analysis, and expression in Escherichia coli
RT   of the cDNA for guanidinoacetate methyltransferase from rat liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:694-698(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3419933; DOI=10.1093/nar/16.17.8715;
RA   Ogawa H., Fujioka M.;
RT   "Nucleotide sequence of the rat guanidinoacetate methyltransferase gene.";
RL   Nucleic Acids Res. 16:8715-8716(1988).
RN   [3]
RP   PROTEIN SEQUENCE OF 22-29, FUNCTION, AND SUBUNIT STRUCTURE.
RX   PubMed=1990977; DOI=10.1016/0003-9861(91)90347-l;
RA   Fujioka M., Takata Y., Gomi T.;
RT   "Recombinant rat guanidinoacetate methyltransferase: structure and function
RT   of the NH2-terminal region as deduced by limited proteolysis.";
RL   Arch. Biochem. Biophys. 285:181-186(1991).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=11165387; DOI=10.1016/s0169-328x(00)00269-2;
RA   Braissant O., Henry H., Loup M., Eilers B., Bachmann C.;
RT   "Endogenous synthesis and transport of creatine in the rat brain: an in
RT   situ hybridization study.";
RL   Brain Res. Mol. Brain Res. 86:193-201(2001).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=15918910; DOI=10.1186/1471-213x-5-9;
RA   Braissant O., Henry H., Villard A.M., Speer O., Wallimann T., Bachmann C.;
RT   "Creatine synthesis and transport during rat embryogenesis: spatiotemporal
RT   expression of AGAT, GAMT and CT1.";
RL   BMC Dev. Biol. 5:9-9(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7] {ECO:0007744|PDB:1KHH}
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 39-236 IN COMPLEX WITH
RP   S-ADENOSYLHOMOCYSTEINE, AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=12079381; DOI=10.1016/s0022-2836(02)00448-5;
RA   Komoto J., Huang Y., Takata Y., Yamada T., Konishi K., Ogawa H., Gomi T.,
RA   Fujioka M., Takusagawa F.;
RT   "Crystal structure of guanidinoacetate methyltransferase from rat liver: a
RT   model structure of protein arginine methyltransferase.";
RL   J. Mol. Biol. 320:223-235(2002).
RN   [8] {ECO:0007744|PDB:1P1B, ECO:0007744|PDB:1P1C}
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 38-236 IN COMPLEX WITH
RP   S-ADENOSYL-L-HOMOCYSTEINE, AND SUBUNIT.
RX   PubMed=12925789; DOI=10.1107/s0907444903014719;
RA   Komoto J., Takata Y., Yamada T., Konishi K., Ogawa H., Gomi T., Fujioka M.,
RA   Takusagawa F.;
RT   "Monoclinic guanidinoacetate methyltransferase and gadolinium ion-binding
RT   characteristics.";
RL   Acta Crystallogr. D 59:1589-1596(2003).
RN   [9] {ECO:0007744|PDB:1XCJ, ECO:0007744|PDB:1XCL}
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH
RP   S-ADENOSYL-L-HOMOCYSTEINE AND GUANIDINOACETATE, AND MUTAGENESIS OF GLU-46;
RP   ASP-135 AND TYR-222.
RX   PubMed=15533043; DOI=10.1021/bi0486785;
RA   Komoto J., Yamada T., Takata Y., Konishi K., Ogawa H., Gomi T., Fujioka M.,
RA   Takusagawa F.;
RT   "Catalytic mechanism of guanidinoacetate methyltransferase: crystal
RT   structures of guanidinoacetate methyltransferase ternary complexes.";
RL   Biochemistry 43:14385-14394(2004).
CC   -!- FUNCTION: Converts guanidinoacetate to creatine, using S-
CC       adenosylmethionine as the methyl donor. Important in nervous system
CC       development. {ECO:0000250|UniProtKB:Q14353}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=guanidinoacetate + S-adenosyl-L-methionine = creatine + H(+) +
CC         S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:10656, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57742, ChEBI:CHEBI:57856, ChEBI:CHEBI:57947,
CC         ChEBI:CHEBI:59789; EC=2.1.1.2; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00892};
CC   -!- PATHWAY: Amine and polyamine biosynthesis; creatine biosynthesis;
CC       creatine from L-arginine and glycine: step 2/2.
CC   -!- SUBUNIT: Monomer. May form homodimers upon proteolytic removal of the
CC       first 36 amino acid residues. {ECO:0000269|PubMed:12079381,
CC       ECO:0000269|PubMed:12925789, ECO:0000269|PubMed:15533043,
CC       ECO:0000269|PubMed:1990977}.
CC   -!- TISSUE SPECIFICITY: Expressed in hepatic primordium in the embryo as
CC       soon as 12.5 days. In the adult, high levels of expression are found in
CC       liver and pancreas. Ubiquitously expressed in neuronal and glial cells
CC       in the brain. {ECO:0000269|PubMed:11165387,
CC       ECO:0000269|PubMed:15918910}.
CC   -!- MISCELLANEOUS: The N-terminal first 36 amino acid residues are
CC       susceptible to proteolytic cleavage, leading to loss of activity.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. RMT2 methyltransferase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00892}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03588; AAA41258.1; -; mRNA.
DR   EMBL; X08056; CAA30845.1; -; Genomic_DNA.
DR   PIR; S01395; S01395.
DR   PDB; 1KHH; X-ray; 2.50 A; A/B=39-236.
DR   PDB; 1P1B; X-ray; 2.80 A; A/B/C/D=38-236.
DR   PDB; 1P1C; X-ray; 2.50 A; A/B=38-236.
DR   PDB; 1XCJ; X-ray; 2.00 A; A=2-236.
DR   PDB; 1XCL; X-ray; 2.00 A; A=2-236.
DR   PDBsum; 1KHH; -.
DR   PDBsum; 1P1B; -.
DR   PDBsum; 1P1C; -.
DR   PDBsum; 1XCJ; -.
DR   PDBsum; 1XCL; -.
DR   AlphaFoldDB; P10868; -.
DR   SMR; P10868; -.
DR   STRING; 10116.ENSRNOP00000036927; -.
DR   iPTMnet; P10868; -.
DR   PhosphoSitePlus; P10868; -.
DR   PaxDb; 10116-ENSRNOP00000036927; -.
DR   UCSC; RGD:2659; rat.
DR   AGR; RGD:2659; -.
DR   RGD; 2659; Gamt.
DR   eggNOG; KOG1709; Eukaryota.
DR   InParanoid; P10868; -.
DR   BioCyc; MetaCyc:MONOMER-7641; -.
DR   BRENDA; 2.1.1.2; 5301.
DR   Reactome; R-RNO-71288; Creatine metabolism.
DR   SABIO-RK; P10868; -.
DR   UniPathway; UPA00104; UER00580.
DR   EvolutionaryTrace; P10868; -.
DR   PRO; PR:P10868; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0030731; F:guanidinoacetate N-methyltransferase activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; IDA:RGD.
DR   GO; GO:0009887; P:animal organ morphogenesis; ISO:RGD.
DR   GO; GO:0006601; P:creatine biosynthetic process; IDA:RGD.
DR   GO; GO:1990402; P:embryonic liver development; IEP:RGD.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0046498; P:S-adenosylhomocysteine metabolic process; IDA:RGD.
DR   GO; GO:0046500; P:S-adenosylmethionine metabolic process; IDA:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   CDD; cd02440; AdoMet_MTases; 1.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR016550; GuanidinoAc_N-MeTrfase.
DR   InterPro; IPR051038; RMT2/GAMT_Mtase.
DR   InterPro; IPR026480; RMT2_dom.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR32379; GUANIDINOACETATE N-METHYLTRANSFERASE; 1.
DR   PANTHER; PTHR32379:SF1; GUANIDINOACETATE N-METHYLTRANSFERASE; 1.
DR   PIRSF; PIRSF009285; GAMT; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   PROSITE; PS51559; SAM_RMT2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Methyltransferase;
KW   Phosphoprotein; Reference proteome; S-adenosyl-L-methionine; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q14353"
FT   CHAIN           2..236
FT                   /note="Guanidinoacetate N-methyltransferase"
FT                   /id="PRO_0000087432"
FT   DOMAIN          13..236
FT                   /note="RMT2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00892"
FT   BINDING         20
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT   BINDING         42
FT                   /ligand="guanidinoacetate"
FT                   /ligand_id="ChEBI:CHEBI:57742"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00892,
FT                   ECO:0000269|PubMed:15533043, ECO:0007744|PDB:1XCJ"
FT   BINDING         46
FT                   /ligand="guanidinoacetate"
FT                   /ligand_id="ChEBI:CHEBI:57742"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00892,
FT                   ECO:0000269|PubMed:15533043, ECO:0007744|PDB:1XCJ"
FT   BINDING         50
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT   BINDING         69..74
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT   BINDING         90..92
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT   BINDING         117..118
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT   BINDING         135
FT                   /ligand="guanidinoacetate"
FT                   /ligand_id="ChEBI:CHEBI:57742"
FT                   /evidence="ECO:0000269|PubMed:15533043,
FT                   ECO:0007744|PDB:1XCJ"
FT   BINDING         135
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT   BINDING         171..172
FT                   /ligand="guanidinoacetate"
FT                   /ligand_id="ChEBI:CHEBI:57742"
FT                   /evidence="ECO:0000269|PubMed:15533043,
FT                   ECO:0007744|PDB:1XCJ"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14353"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         46
FT                   /note="E->D: Reduces affinity for substrate and S-adenosyl-
FT                   L-methionine about 2-fold."
FT                   /evidence="ECO:0000269|PubMed:15533043"
FT   MUTAGEN         46
FT                   /note="E->Q: Reduces affinity for substrate and S-adenosyl-
FT                   L-methionine about 4-fold."
FT                   /evidence="ECO:0000269|PubMed:15533043"
FT   MUTAGEN         46
FT                   /note="E->S: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:15533043"
FT   MUTAGEN         135
FT                   /note="D->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:15533043"
FT   MUTAGEN         135
FT                   /note="D->E: Reduces affinity for S-adenosyl-L-methionine
FT                   500-fold. Reduces affinity for substrate about 40-fold."
FT                   /evidence="ECO:0000269|PubMed:15533043"
FT   MUTAGEN         135
FT                   /note="D->N: Reduces affinity for S-adenosyl-L-methionine
FT                   2000-fold. Reduces affinity for substrate about 40-fold."
FT                   /evidence="ECO:0000269|PubMed:15533043"
FT   MUTAGEN         222
FT                   /note="Y->F: Reduces affinity for S-adenosyl-L-methionine
FT                   about 5-fold. Reduces affinity for substrate about 40-
FT                   fold."
FT                   /evidence="ECO:0000269|PubMed:15533043"
FT   HELIX           17..20
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          33..36
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          39..43
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           44..46
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           47..57
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   TURN            58..60
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          62..67
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           73..80
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          84..90
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           93..103
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          107..115
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           117..120
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           121..123
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          129..134
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           141..143
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   TURN            144..146
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           147..154
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           156..159
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          160..168
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           171..180
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           185..192
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           194..200
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   HELIX           204..206
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          207..213
FT                   /evidence="ECO:0007829|PDB:1XCJ"
FT   STRAND          226..234
FT                   /evidence="ECO:0007829|PDB:1XCJ"
SQ   SEQUENCE   236 AA;  26407 MW;  738D6F0BC86DB1C3 CRC64;
     MSSSAASPLF APGEDCGPAW RAAPAAYDTS DTHLQILGKP VMERWETPYM HSLAAAAASR
     GGRVLEVGFG MAIAASRVQQ APIKEHWIIE CNDGVFQRLQ NWALKQPHKV VPLKGLWEEE
     APTLPDGHFD GILYDTYPLS EETWHTHQFN FIKTHAFRLL KPGGILTYCN LTSWGELMKS
     KYTDITAMFE ETQVPALLEA GFQRENICTE VMALVPPADC RYYAFPQMIT PLVTKH
//
